Uncategorized

Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs

Published

on

Ying Huang is now running K2 Therapeutics, which has licensed multiple prospects from China-based biotechs and is searching for more “high-potential” medicines.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version